3 (Glipizide Extended-Release 5 mg)
Pill with imprint 3 is Orange, Round and has been identified as Glipizide Extended-Release 5 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 3
Glipizide Extended-Release
- Imprint
- 3
- Strength
- 5 mg
- Color
- Orange
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Sulfonylureas
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0336
- Inactive Ingredients
-
acetyltributyl citrate,
ammonia,
butyl alcohol,
FD&C Yellow No. 6,
ferrosoferric oxide,
hydroxyethyl cellulose (2000 mpa.s at 1%),
hypromelloses,
isopropyl alcohol,
lactose monohydrate,
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:1),
polyethylene glycol,
propylene glycol,
shellac,
silicon dioxide,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "3"
More about glipizide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (64)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: sulfonylureas
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.